Cayman Islands vs Saint Martin (French Part): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cayman Islands
0.2%
in 2024
Saint Martin (French Part)
0.2%
in 2024
Cayman Islands rank
98th
Saint Martin (French Part) rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cayman Islands
- Saint Martin (French Part)
How they compare
Cayman Islands currently reports 0.2% against 0.2% in Saint Martin (French Part), a difference of 0.0%.
Across all 10 years both countries report, Saint Martin (French Part) has been ahead every year.
Cayman Islands ranks 98th and Saint Martin (French Part) ranks 98th of 246 countries.
Head to head by decade
| Decade | Cayman Islands | Saint Martin (French Part) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cayman Islands or Saint Martin (French Part)?
- Cayman Islands, at 0.2% against 0.2% in Saint Martin (French Part) as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cayman Islands and Saint Martin (French Part)?
- 0.0%, with Cayman Islands ahead.
- How many years of comparable data are there for Cayman Islands and Saint Martin (French Part)?
- 10 years are reported by both, from 2015 to 2024.
- How do Cayman Islands and Saint Martin (French Part) rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cayman Islands ranks 98th and Saint Martin (French Part) ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.